glp-1 shortage canada news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our GLP-1 Receptor Agonist Market Size

The practical effect: you feel full faster, stay full longer, and experience less food noise (constant thoughts about food, cravings, snacking urges)

Williams, is that the second you remove the tool (GLP-1 medication), you'll go right back to feeling hungry and craving unhealthy foods

Strategies for breaking through Dose adjustment is the most direct pharmacological approach

Graphical abstract Fig

Yes, orforglipron is an oral GLP-1 receptor agonist currently under development, showing promising results in clinical trials for glycemic control and weight loss

A plan of adjusting insulin doses, especially when travelling across time zones, is essential to reduce glucose fluctuations [162]